The store will not work correctly when cookies are disabled.
3-(m-tolyl)-2-[2-(3-pyridyl)vinyl]quinazolin-4-one
ID: ALA4547960
PubChem CID: 5729808
Max Phase: Preclinical
Molecular Formula: C22H17N3O
Molecular Weight: 339.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(-n2c(/C=C/c3cccnc3)nc3ccccc3c2=O)c1
Standard InChI: InChI=1S/C22H17N3O/c1-16-6-4-8-18(14-16)25-21(12-11-17-7-5-13-23-15-17)24-20-10-3-2-9-19(20)22(25)26/h2-15H,1H3/b12-11+
Standard InChI Key: UDXOKVRGXFJGFJ-VAWYXSNFSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
10.6572 -4.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3652 -3.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0693 -4.2490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0693 -5.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3677 -5.4749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6572 -5.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7816 -5.4761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4896 -5.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4896 -4.2490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7816 -3.8372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7816 -3.0181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1974 -3.8374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1977 -3.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9071 -2.6134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6152 -3.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6174 -3.8344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9095 -4.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3252 -4.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1974 -5.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9052 -5.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6171 -5.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3251 -5.0646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0292 -5.4754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0292 -6.2948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3276 -6.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6171 -6.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
3 10 1 0
10 11 2 0
12 9 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
16 18 1 0
8 19 1 0
19 20 2 0
20 21 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.40 | Molecular Weight (Monoisotopic): 339.1372 | AlogP: 4.26 | #Rotatable Bonds: 3 |
Polar Surface Area: 47.78 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.86 | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.56 | Np Likeness Score: -1.35 |
References
1. (2017) Arf6 inhibitors and methods of synthesis and use thereof, |